Skip to main content
Clinical Trials/CTRI/2021/08/035810
CTRI/2021/08/035810
Not yet recruiting
未知

Developing clinical high efficiency platforms for individualised treatment through integration ofadvanced radiation technology, quantitative imaging and molecular biology and machinelearning for treatment of cervix cancer.

Science and Engineering Research Board SERB0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Sponsor
Science and Engineering Research Board SERB
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Science and Engineering Research Board SERB

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients treated within ongoing and completed clinical trials of chemoradiation and brachytherapy for cervix cancer with access to MRI/CT images at the time of diagnosis and brachytherapy.
  • 2\. Patients undergoing postoperative or definitive radiotherapy and treated within trials of postoperative or definitive RT.

Exclusion Criteria

  • 1\. Lack of disease or toxicity outcomes.
  • 2\. Lack of images in the hospital database.

Outcomes

Primary Outcomes

Not specified

Similar Trials